Hostname: page-component-788cddb947-t9bwh Total loading time: 0 Render date: 2024-10-14T12:00:28.530Z Has data issue: false hasContentIssue false

Meta-Analysis of Controlled Pharmacologic Trials

Published online by Cambridge University Press:  07 January 2005

Lon S. Schneider
Affiliation:
Department of Psychiatry and the Behavioral Sciences, University of Southern California School of Medicine, Los Angeles, California, U.S.A.

Extract

Both pharmacologic and nonpharmacologic methods can be used to treat behavioral disturbances of dementia. Many drugs and drug classes have been advocated as having putative efficacy in treating nonspecific behavioral symptoms; the list includes neuroleptics, anxiolytics, antidepressants (e.g., trazodone), anticonvulsants (e.g., carbamazepine and valproic acid), lithium, β-adrenergic blockers, selegiline, and buspirone. Neuroleptics are among the most commonly prescribed psychotropic drugs for behavioral symptoms and have been described as being “modestly effective” in controlling agitation, both in patients with dementia and in elderly patients in general. To examine the relative efficacy of neuroleptics in treating behavioral disturbances of dementia, the author and colleagues performed a meta-analysis of clinical trials published in the literature from 1954 to 1989.

Type
Criterion Validity: Do the Symptoms Respond to Treatment—Pharmacologic or Nonpharmacologic?
Copyright
© 1996 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)